Chemoinformaics analysis of Stigmasterol glucoside
| Molecular Weight | 574.843 | nRot | 8 |
| Heavy Atom Molecular Weight | 516.379 | nRig | 2 |
| Exact Molecular Weight | 574.423 | nRing | 5 |
| Solubility: LogS | -4.015 | nHRing | 1 |
| Solubility: LogP | 5.515 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 101.936 |
| nHD | 4 | BPOL | 61.658 |
| QED | 0.414 |
| Synth | 2.14 |
| Natural Product Likeliness | 1.314 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.755 |
| MDCK | 0.0000274 |
| BBB | 0.553 |
| PPB | 0.977367 |
| VDSS | 0.387 |
| FU | 0.0176903 |
| CYP1A2-inh | 0.136 |
| CYP1A2-sub | 0.183 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.159 |
| CYP2c9-inh | 0.336 |
| CYP2c9-sub | 0.982 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.083 |
| CYP3a4-inh | 0.026 |
| CYP3a4-sub | 0.026 |
| CL | 3.115 |
| T12 | 0.733 |
| hERG | 0.013 |
| Ames | 0.005 |
| ROA | 0.019 |
| SkinSen | 0.928 |
| Carcinogencity | 0.205 |
| EI | 0.991 |
| Respiratory | 0.429 |
| NR-Aromatase | 0.041 |
| Antiviral | No |
| Prediction | 0.611327 |